Status:
UNKNOWN
The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Obesity
Polycystic Ovaries Syndrome
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
The first aim of the investigators study, was to investigate the combined effect of diet,physical exercise and orlistat, for 24 weeks, on serum Anti-Müllerian Hormone (AMH) levels in obese women with ...
Detailed Description
The first aim of our study, was to investigate the combined effect of diet,physical exercise and orlistat, for 24 weeks, on serum Anti-Müllerian Hormone (AMH) levels in obese women with polycystic ova...
Eligibility Criteria
Inclusion
- premenopausal,
- nonpregnant,
- nonlactating,
- overweight and obese women
Exclusion
- classical 21-hydroxylase deficiency,
- hyperprolactinemia,
- adrenal or ovarian tumor and Cushing's disease
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01475019
Start Date
January 1 2004
End Date
December 1 2012
Last Update
November 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aristotle University of Thessaloniki Medical School
Thessaloniki, Thessaloniki, Greece, 54124